NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation […]
NHC Comments on Negotiation Data Elements and Drug Price Negotiation Process for Initial Price Applicability Year 2027 under Sections 11001 and 11002 of the IRA ICR Forms
NHC Comments on Negotiation Data Elements and Drug Price Negotiation Process for Initial Price Applicability Year 2027 under Sections 11001 and 11002 of the Inflation Reduction Act (IRA) Information Collection […]
Institute for Clinical and Economic Review’s (ICER) Unsupported Price Increase Assessment
The National Health Council (NHC) is pleased to provide comments on the Institute for Clinical and Economic Review’s (ICER) solicitation for feedback on the Unsupported Price Increase Assessment draft protocol. […]
NHC Medicare Drug Price Negotiation Program Comments
NHC Medicare Drug Price Negotiation Program Comments By: Allen Pinn, Coordinator, Policy April 14, the National Health Council (NHC) submitted comments to the Centers for Medicare & Medicaid Services (CMS) […]
NHC Provides Input on Patient Engagement in Medicare Drug Price Negotiations
NHC Provides Input on Patient Engagement in Medicare Drug Price Negotiations By: Allen Pinn, Coordinator, Policy August 16 marked two years since the Inflation Reduction Act (IRA) was signed into […]
NHC Comments on Information Collection Request for Drug Price Negotiation by IRA
NHC Comments on Information Collection Request for Drug Price Negotiation by IRA (PDF) May 22, 2023 Chiquita Brooks-LaSure Administrator Centers for Medicare & Medicaid Services Department of Health and Human […]
NHC Comments on Request for Information: Medicare Transaction Facilitator (MTF) for the Medicare Drug Price Negotiation Program
NHC Comments on Request for Information: Medicare Transaction Facilitator (MTF) for the Medicare Drug Price Negotiation Program (PDF) November 13, 2023 Benjamin Stidham, Contract Specialist Centers for Medicare & Medicaid […]
Meaningful Patient Engagement Will Be Key to Successful Drug Price Negotiation
Meaningful Patient Engagement Will Be Key to Successful Drug Price Negotiation By: Randall Rutta, CEO, National Health Council On Tuesday, August 29, the Biden Administration announced the first 10 drugs […]
Advance Notice of Proposed Rulemaking: International Price Index Model for Medicare Part B Drugs
The National Health Council (NHC) appreciates the opportunity to respond to the Centers for Medicare & Medicaid Services’ (CMS’) Advance Notice of Proposed Rulemaking entitled, “International Price Index Model for […]
Consent Designed For Patients By Patients: A New Consent Standard For Patients Participating In Life-Saving Research
Consent Designed For Patients By Patients: A New Consent Standard For Patients Participating In Life-Saving Research Event Time: 2:00 p.m. ET Event Location: Webex This webinar featured a presentation on […]